Enzyme

📍 South San Francisco, United States🗓 Founded 2017👥 38 employees💰 Last funded May 2018
Software Development🌐 enzyme.com
Website LinkedIn
Enzyme’s mission is to automate and simplify life science regulatory approval and compliance. We reduce your cost of compliance and help bring your cutting-edge technology to market faster. Our cloud based Quality Management System (QMS) streamlines documentation and integrates with tools you are already using. And our experts guide you through your entire regulatory and compliance lifecycle: from pre-submission, to product design and development, regulatory submission, and post-market compliance. Enzyme supports all life science companies, with an emphasis on companies making digital health, or software as a medical device (SaMD), products.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Enzyme?
Enzyme has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Enzyme last raise funding?
The most recent investment in Enzyme recorded on gritt.io was in May 2018.
When was Enzyme founded?
Enzyme was founded in 2017.
What industry is Enzyme in?
Enzyme operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Enzyme based?
Enzyme is headquartered in South San Francisco, United States.